RLX HCl is a narcissus ketone analogue with anticancer activity that inhibits tumour proliferation by suppressing the PI3K/Akt/FoxO3a signalling pathway in experimental colon cancer, downregulating the p110alpha and p85 subunits of PI3K in HCT-116 cells, and exhibiting antiproliferative effects.
Molekulargewicht:
250.72
Reinheit:
99.43% (May vary between batches)
CAS Nummer:
[21314-60-3]
Formel:
C13H15ClN2O
Target-Kategorie:
FOXO,PI3K,Akt
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten